KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
By:
Business Wire
May 22, 2025 at 21:01 PM EDT
Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.
Contacts
Media Contact
Naomi Goumillout
Agilent Technologies
+1.978.314.1862
naomi.goumillout@agilent.com
More News
View More
BJ’s Wholesale Club and the Case for a Bullish Market Reversal ↗
Today 11:45 EST
Via MarketBeat
Tickers
BJ
Why Costco Stock May Struggle Even as Its Business Thrives ↗
Today 10:31 EST
3 High Growth Revenue Stocks That Wall Street Loves ↗
Today 8:21 EST
Via MarketBeat
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>